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Quantification of Cell Signaling Networks 
Using Kinase Activity Chemosensors
Jon R. Beck, Edward N. Harris, and Cliff I. Stains
University of Nebraska–Lincoln
Abstract 
The ability to directly determine endogenous kinase activity in tissue homogenates 
provides valuable insights into signaling aberrations that underlie disease pheno-
types. When activity data is collected across a panel of kinases, a unique “signal-
ing fingerprint” is generated that allows for discrimination between diseased and 
normal tissue. Here we describe the use of peptide-based kinase activity sensors 
to fingerprint the signaling changes associated with disease states. This approach 
leverages the phosphorylation-sensitive sulfonamido-oxine (Sox) fluorophore to 
provide a direct readout of kinase enzymatic activity in unfractionated tissue ho-
mogenates from animal models or clinical samples. To demonstrate the applica-
tion of this technology, we focus on a rat model of nonalcoholic fatty liver disease 
(NAFLD). Sox-based activity probes allow for the rapid and straightforward anal-
ysis of changes in kinase enzymatic activity associated with disease states, pro-
viding leads for further investigation using traditional biochemical approaches. 
Keywords: Kinase activity assay, Cell signaling, Nonalcoholic fatty liver disease, 
Phosphorylation, Fluorescence-based biosensor 
1 Introduction
Quantification of kinase enzymatic activity has traditionally been 
accomplished by monitoring the transfer of radioactive phosphate 
from [γ-32P]ATP to a peptide or protein substrate [1–3]. While pow-
erful in terms of general applicability across the kinome, this method 
of activity determination may be difficult to implement in samples 
containing multiple kinases, such as tissue homogenates, due to the 
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inherent promiscuity of [γ-32P]ATP. Additionally, the use of radioac-
tivity presents potential hazards to users and requires specialized 
training as well as dedicated equipment. In contrast, peptide-based 
substrates that rely on a change in fluorescence upon phosphory-
lation as a readout of kinase activity present an alternative for the 
straightforward analysis of kinase activity [4]. Such probes may be 
used to directly report on kinase enzymatic activity in unfraction-
ated cell lysates or tissue homogenates, provided that sufficiently se-
lective peptide substrates can be identified [5–7]. Here, we describe 
the use of peptide substrates that utilize the phosphorylation-sensi-
tive Sox fluorophore to report on kinase activity. Sox-based probes 
produce an increase in fluorescence (ex = 360 nm, em = 485 nm) 
upon phosphorylation, through a process termed chelation-enhanced 
fluorescence (CHEF) [8]. Controlling the concentration of Mg2+ in 
the assay allows for discrimination between the phosphorylated and 
nonphosphorylated probe since binding affinities for Mg2+ generally 
improve by an order of magnitude upon phosphorylation. First-gen-
eration Sox sensors relied on a β-turn motif to provide efficient Mg2+ 
binding upon phosphorylation [9, 10]. Though powerful, incorpo-
ration of the β-turn motif resulted in removal of the substrate se-
quence either N- or C-terminal to the site of phosphorylation. In or-
der to improve kinase selectivity, a second-generation approach was 
described in which a single amino acid in a peptide substrate is mu-
tated to cysteine. Subsequent alkylation with the Sox fluorophore re-
sults in generation of a CSox-based probe with a single amino acid 
mutation relative to the wild-type sequence (Fig. 1a) [11]. Due to the 
increased flexibility of the cysteine side chain, efficient Mg2+ binding 
upon phosphorylation is retained in CSox-based sensor constructs. 
Moreover, kinetic parameters for target kinases can be significantly 
improved [11]. Recent work has identified a panel of CSox-based ki-
nase activity probes for p38α, MK2, Akt, ERK1/ERK2, and PKA (Ta-
ble 1) [11–13] that can be utilized to interrogate signaling changes 
in unfractionated cell lysates or tissue homogenates (Fig. 1b) [5]. In 
some cases, selectivity is achieved by utilizing broad spectrum inhib-
itors to suppress the activity of off-target enzymes while preserving 
signal from the target enzyme [5, 13, 14]. In addition to these val-
idated probes (Table 1), numerous Sox-based substrates capable of 
reporting on kinase activity in vitro have been reported, including 
sensors for focal adhesion kinase [15], leucine-rich repeat kinase 2 
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Fig. 1. Monitoring endogenous kinase activity with CSox-based chemosensors. (a) 
The Sox fluorophore is incorporated near the site of phosphorylation on a known 
peptide substrate that is selective for the kinase of interest. Following phosphory-
lation by the kinase of interest, the Sox fluorophore undergoes CHEF in the pres-
ence of Mg2+. The increase in signal due to CHEF is measured over time. The result-
ing data is proportional to the rate of phosphorylation of the probe. (b) Selective 
CSox-based chemosensors can resolve the activity of a target kinase in the pres-
ence of off-target enzymes. Differences in kinase activity can be readily quantified 
between disease and normal phenotypes  
Table 1. CSox-based chemosensors used in this protocol 
Kinase  Substrate sequence  Pathway  Reference 
p38α  RKPDLRVVIPP-(AOO)3-QP-CSox-ASPVVa  Inflammation  [13] 
MK2  AHLQRQLSI-CSox-HH  Inflammation  [11] 
PKA  ALRRASL-CSox-AA  Metabolism  [11] 
Akt  ARKRERAYSF-CSox-HHA  Survival  [11] 
ERK1/ERK2  VP-CSox-LTPGGRRG-PNT Domain(S46-K138)b  Growth  [12] 
a. AOO is an 8-amino-3,6-dioxaoctanoic acid linker 
b. This probe is synthesized by ligating a CSox-containing peptide to a protein domain 
termed PNT  
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[16], rho-associated protein kinase [17], and spleen tyrosine kinase 
[18, 19]. Further optimization of these probes for use in unfraction-
ated cell lysates or tissue homogenates will allow for broader cov-
erage of signaling pathways. Beyond detection of protein kinase ac-
tivity, we have recently demonstrated that CSox-based probes can 
be repurposed to detect the activity of endogenous protein phospha-
tases [20]. This battery of validated CSox-based assays allows for 
the fundamental investigation of signaling perturbations associated 
with disease states. 
In this chapter, we provide detailed protocols for generating tis-
sue homogenates that preserve endogenous kinase activity as well 
as instructions for assay setup and data analysis. As a case study, we 
include data generated from a rat model of NAFLD [21, 22] to illus-
trate the application of this methodology. In addition to rat liver tis-
sues, this protocol has been used to analyze kinase activity in several 
other tissue types including the human breast, lung, and prostate [5]. 
Lastly, this general procedure may be adapted for new CSox-based 
probes [23] as they become available. 
2 Materials
2.1 Tissue Homogenate Preparation Components 
1.  Ice. 
2.  2.0 ml screw cap cryotubes. 
3.  15 ml conical tubes. 
4.  1000 ml micropipette with tips. 
5.  Cold PBS. 
6.  Lysis buffer: 50 mM Tris–HCl, pH 7.5 at 22 °C, 150 mM NaCl, 
100 μM Na3VO4, 1% Triton X-100, 1× Protease Inhibitor Cocktail 
III (EMD Millipore Cocktail, 539134), 1× Phosphatase Inhibitor 
Cocktail III (Sigma, P0044), 1 mM DTT, and 2 mM EGTA. Store 
up to 6 months at –20 °C. 
7.  Homogenizer. 
8.  Temperature-controlled microcentrifuge. 
9.  1.7 ml microcentrifuge tubes. 
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10.  Liquid nitrogen. 
11.  Low-form Dewar flask. 
12.  0.7 ml microcentrifuge tubes. 
2.2 Kinase Activity Assay Components
1.  Total protein assay. 
2.  Fluorescence microplate reader. 
3.  384-well, half-area, white microplate (Corning, 3824). 
4. 10× Master Mix: 500 mM Tris–HCl, pH = 7.5 at 22 °C, 20 mM 
EGTA, 0.1% Brij-35, 10 mM DTT, 100 mM MgCl2, and 10 mM ATP 
(store at –20 °C). 
5. 10× kinase activity sensor (all dissolved in nanopure H2O) (see 
Note 1): 
  (a) 25 μM Akt chemosensor. 
  (b) 10 μM p38α chemosensor. 
  (c) 25 μM MK2 chemosensor. 
  (d) 100 μM PKA chemosensor. 
  (e) 50 μM ERK1/ERK2 chemosensor. 
6. 10× inhibitor cocktails (diluted in DMSO; store at –20 °C) (see 
Note 2): 
(a) Akt: 40 μ MPKC inhibitor peptide, 40 μM calmidazolium, 
and 50 μM GF109203X. 
(b) p38α: 10 μM staurosporine (and 10 μM SB203580 in p38α-
inhibited wells; see Note 3). 
(c) MK2: no inhibitors required. 
(d) PKA: 40 μM PKC inhibitor peptide, 40 μM calmidazolium, 
and 50 μM GF109203X. 
(e) ERK1/ERK2: no inhibitors required. 
7.  Multichannel pipette. 
8.  Ice. 
9.  Lysis buffer: see component 6, Subheading 2.1. 
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3 Methods
3.1 Preparation of Tissue Homogenates
1.  Following tissue extraction, samples should immediately be 
placed in cold screw cap cryotubes, labeled, and flash frozen in 
liquid nitrogen. 
2.  Flash-frozen samples should then be stored at –80 °C until they 
are homogenized (see Note 4). 
3.  Prior to removing cryotube samples from the –80 °C freezer, 
weigh 15 ml conical tubes sufficient for the number of samples 
that are to be homogenized, and place the conical tubes on ice. 
4.  Remove the frozen cryotube samples one at a time, and, using 
a clean razor blade, cut off approximately 100 mg of tissue and 
place in a chilled conical tube. Place the conical tube back on ice, 
and return any unused sample to its cryotube and immediately 
return to the –80 °C freezer. 
5.  Repeat step 4 until all of the samples have been placed in coni-
cal tubes. 
6.  Weigh each conical tube again and determine the mass of each 
sample. 
7.  To each sample, add 2 ml of cold phosphate-buffered saline (PBS) 
to wash the samples (see Note 5). 
8.  Remove and discard the used PBS with at 1000 μl pipette. 
9.  Repeat steps 7 and 8 until the PBS wash is clear. 
10.  Add lysis buffer to each tissue sample (3 μl/mg). 
11.  Homogenize each sample in lysis buffer on ice (see Note 6). 
12.  Allow the samples to incubate for 15 min on ice. 
13.  While the samples are incubating, cool a microcentrifuge to 4 °C, 
and label a sufficient number of 1.7 ml microcentrifuge tubes for 
each sample. Place the empty tubes on ice. 
14.  Using a 1000 μl micropipette, transfer each homogenized sam-
ple from their respective conical tubes to the appropriately la-
beled microcentrifuge tubes, and return to the ice. 
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15.  After all of the samples have been transferred to microcentrifuge 
tubes, place the tubes in the cooled microcentrifuge, and centri-
fuge for 5 min at 15,000 rcf. 
16.  While the samples are centrifuging, label additional 1.7 ml mi-
crocentrifuge tubes for each sample, and place on ice. 
17.  Remove the homogenates from the microcentrifuge and return 
them to the ice. 
18.  Using a 1000 μl pipette, carefully remove the soluble fraction 
from each tube, and place in the appropriately labeled new mi-
crocentrifuge tube from step 16. Discard the pellets (see Note 7). 
For storage of the samples, follow steps 19–21; otherwise, pro-
ceed to Subheading 3.2. 
19.  Add liquid nitrogen to a low-form Dewar flask. 
20.  For each sample, aliquot 10 μl of the soluble fraction to labeled 
0.7 ml microcentrifuge tubes until the sample has all been al-
iquoted. Immediately flash freeze the aliquoted samples in the 
liquid nitrogen. 
21.  Following flash freezing, place all samples in a –80 °C freezer 
for storage. 
3.2 Quantifying Kinase Activity  
in Tissue Homogenates
1.  Determine the total protein concentration of each homogenized 
sample using a total protein assay (see Note 8). 
2.  Turn on the microplate reader and equilibrate to 30 °C. 
3.  Obtain a 384-well microplate (see Subheading 2.2). 
4.  Add 4 μl of 10× Master Mix into each well intended to be used for 
activity determination. The assay should be conducted in tripli-
cate for each sample. Due to the off-target subtraction required 
for p38α analysis, six wells will be needed per sample for this ki-
nase: three for p38α activity determination and three for back-
ground subtraction. 
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5.  Add 4 μl of the desired 10× Kinase Activity Sensor to each well. 
6.  Add 4 μl of 10× inhibitor cocktail as required for the specific ki-
nase activity assay. 
7.  Dilute each well to 36 μl total volume with nanopure H2O. 
8.  Mix the wells with a multichannel pipette, displacing ~20% of 
the well volume per mix. 
9.  Place the plate into the microplate reader for 10 min to equili-
brate the assay components to the assay temperature. 
10.  Following equilibration, collect fluorescence data on the wells 
for 10 min (1 min between reads, λex = 360 nm, λem = 485 nm) 
in order to identify any aberrant wells prior to activity determi-
nation. Wells with significantly different fluorescence readings 
(10%) should be discarded, and another well should be prepared. 
11.  While the plate is equilibrating and being read, remove one ali-
quot for each sample to be assayed from the –80 °C freezer, and 
place on ice. 
12.  Dilute each sample with cold lysis buffer to the ideal concentra-
tion for the kinase being assayed (0.83 μg/μl for Akt, p38α, and 
MK2, 1.67 μg/μl for PKA, and 3.33 μg/μl for ERK1/ ERK2) (see 
Note 9). 
13.  Following the 10 min read period, remove the plate from the 
microplate reader, and add 4 μl of diluted homogenate per well 
based on the kinase being assayed. 
14.  Following the addition of homogenate to all wells, quickly mix 
the assays with a multichannel pipette by displacing ~20% of 
the total volume multiple times (see Note 10). 
15.  Place the plate back in the microplate reader, and read for 2 h 
using the same conditions as in step 10 (see Note 11). 
16.  Following the completion of the assay, remove the plate and 
cover all unused wells to protect them from accumulation of 
particulate matter (see Note 12). 
17.  The initial linear portion of the kinetic data for each sample can 
now be fit to a linear line (Fig. 2a). The slope of this line is pro-
portional to the reaction rate (see Note 13). 
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18.  Average the reaction slopes of each triplicate sample set, and cal-
culate the standard deviation. Significance can be determined 
using a two-tailed student’s t-test. For the p38α assay, the av-
erage slope of the SB203580-containing wells should be back-
ground subtracted from the average slope of wells not contain-
ing SB203580 in order to obtain the activity due to p38α. 
19.  The average reaction slope can also be determined among 
groups of similar homogenates (diseased vs. control) by aver-
aging the mean of each triplicate experiment across each sam-
ple type (Fig. 2b). 
4 Notes
1.  The synthesis of each validated kinase chemosensor has been de-
scribed in the literature [11–13]. Alternatively, custom Sox-based 
peptides are currently available from AssayQuant Technologies 
Inc. Additional CSox-based chemosensors that have been vali-
dated for use in complex biological systems [23] could be used 
similarly to those described in this protocol. 
Fig. 2. Analysis of kinase activity in a rat model of NAFLD. (a) Representative raw 
data for an MK2 assay using rat liver homogenates. A clear decrease in the rate of 
phosphorylation of the MK2 probe is observed in NALFD (triangles) versus con-
trol (circles) homogenates. (b) A profile of kinase activity from NAFLD and con-
trol liver homogenates (n = 6 animals, assays run in triplicate for each animal). 
Activities are presented relative to respective control reactions for each enzyme    
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2.  The suggested concentrations are such as to provide for 10% 
DMSO (v/v) in the final assay. We have found that up to 10% 
(v/v) of DMSO does not significantly alter kinase activity. 
3.  The p38α assay requires two reactions to be run: (a) inhibited 
with staurosporine (allows for p38α detection and suppression 
of some but not all off-target activity) and (b) inhibited with 
both staurosporine and SB203580 (inhibits p38α activity but not 
remaining off-target activity). Background subtraction of wells 
with SB203580 from wells without allows for resolution of p38α 
activity [13]. 
4.  These tissue samples can be stored for over 6 months without 
appreciable loss of kinase activity. 
5.  This step removes excess blood and fluid from the tissue sample. 
6.  Our laboratory typically uses a handheld tissue homogenizer 
(Omni, TH115-PCRH) with disposable, hard tissue tips (Omni, 
30750H). Other types of homogenizers may be used. Homog-
enization times should be kept as short as possible in order to 
avoid excessive sample heating. Use short bursts from the ho-
mogenizer until the tissue has been sufficiently broken down. 
7.  After centrifugation, a thin, cloudy lipid layer may appear on top 
of the soluble fraction. Avoid collecting the lipid layer by pierc-
ing it with the pipette tip before beginning to collect the soluble 
fraction. Once the soluble fraction has been collected and trans-
ferred to the new 1.7 ml microcentrifuge tube, mix with the pi-
pette to increase the homogeneity of the sample. 
8.  Once a sample has been thawed for any reason, it should not be 
refrozen and used for activity assays. Freeze-thawed samples 
can be saved and used for Western blotting. 
9.  These concentrations allow for the optimized final total protein 
to be added to each well: 3.3 μg for Akt, p38α and MK2; 6.7 μg 
for PKA; and 13.2 μg for ERK1/ERK2. 
10.  Take care not to introduce bubbles when adding diluted homoge-
nate to the assay wells as well as when mixing. Avoid this by not 
injecting air into the mixture. Large bubbles may be dispersed 
with a hypodermic needle, but small bubbles are difficult to re-
move and will adversely influence the assay results. 
Beck ,  Harris ,  &  Sta ins  in  Kinase  S ignal ing  Networks  (2017)       11
11.  Comparison of fluorescence to wells prior to addition of lysate 
allows for identification of reactions in which a large proportion 
of substrate turnover has occurred prior to reading. In order to 
obtain the linear region of the reaction, less lysate may be used. 
12.  Plates may be used multiple times, but individual assay wells 
should not be reused. 
13.  At times, there may be a lag phase before the fluorescence inten-
sity begins to increase [14]. If this phenomenon occurs, only fit 
the linear trend line to the data after the increase is observed. 
Furthermore, if the data becomes hyperbolic as the reaction pro-
ceeds, only fit a linear trend line to the initial linear portion of 
the reaction curve. In all cases, the same time period should be 
used for each sample assaying the same kinase, so as to main-
tain consistency in the data. 
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